188 related articles for article (PubMed ID: 16738312)
1. Visualizing dynamic E2F-mediated repression in vivo.
Agromayor M; Wloga E; Naglieri B; Abrashkin J; Verma K; Yamasaki L
Mol Cell Biol; 2006 Jun; 26(12):4448-61. PubMed ID: 16738312
[TBL] [Abstract][Full Text] [Related]
2. Interaction of E2F-Rb family members with corepressors binding to the adjacent E2F site.
Nakajima Y; Yamada S; Kamata N; Ikeda MA
Biochem Biophys Res Commun; 2007 Dec; 364(4):1050-5. PubMed ID: 17976373
[TBL] [Abstract][Full Text] [Related]
3. Geminin is targeted for repression by the retinoblastoma tumor suppressor pathway through intragenic E2F sites.
Markey M; Siddiqui H; Knudsen ES
J Biol Chem; 2004 Jul; 279(28):29255-62. PubMed ID: 15084580
[TBL] [Abstract][Full Text] [Related]
4. Disruption of Rb/E2F pathway results in increased cyclooxygenase-2 expression and activity in prostate epithelial cells.
Davis JN; McCabe MT; Hayward SW; Park JM; Day ML
Cancer Res; 2005 May; 65(9):3633-42. PubMed ID: 15867358
[TBL] [Abstract][Full Text] [Related]
5. MAZ induces MYB expression during the exit from quiescence via the E2F site in the MYB promoter.
Álvaro-Blanco J; Urso K; Chiodo Y; Martín-Cortázar C; Kourani O; Arco PG; Rodríguez-Martínez M; Calonge E; Alcamí J; Redondo JM; Iglesias T; Campanero MR
Nucleic Acids Res; 2017 Sep; 45(17):9960-9975. PubMed ID: 28973440
[TBL] [Abstract][Full Text] [Related]
6. Hierarchical requirement of SWI/SNF in retinoblastoma tumor suppressor-mediated repression of Plk1.
Gunawardena RW; Siddiqui H; Solomon DA; Mayhew CN; Held J; Angus SP; Knudsen ES
J Biol Chem; 2004 Jul; 279(28):29278-85. PubMed ID: 15105433
[TBL] [Abstract][Full Text] [Related]
7. Basal repression of BRCA1 by multiple E2Fs and pocket proteins at adjacent E2F sites.
Bindra RS; Glazer PM
Cancer Biol Ther; 2006 Oct; 5(10):1400-7. PubMed ID: 17106239
[TBL] [Abstract][Full Text] [Related]
8. Distinct recruitment of E2F family members to specific E2F-binding sites mediates activation and repression of the E2F1 promoter.
Araki K; Nakajima Y; Eto K; Ikeda MA
Oncogene; 2003 Oct; 22(48):7632-41. PubMed ID: 14576826
[TBL] [Abstract][Full Text] [Related]
9. Tandem E2F binding sites in the promoter of the p107 cell cycle regulator control p107 expression and its cellular functions.
Burkhart DL; Wirt SE; Zmoos AF; Kareta MS; Sage J
PLoS Genet; 2010 Jun; 6(6):e1001003. PubMed ID: 20585628
[TBL] [Abstract][Full Text] [Related]
10. RB family tumor suppressor activity may not relate to active silencing of E2F target genes.
Vormer TL; Wojciechowicz K; Dekker M; de Vries S; van der Wal A; Delzenne-Goette E; Naik SH; Song JY; Dannenberg JH; Hansen JB; Te Riele H
Cancer Res; 2014 Sep; 74(18):5266-76. PubMed ID: 25056122
[TBL] [Abstract][Full Text] [Related]
11. Loss of E2F-1 reduces tumorigenesis and extends the lifespan of Rb1(+/-)mice.
Yamasaki L; Bronson R; Williams BO; Dyson NJ; Harlow E; Jacks T
Nat Genet; 1998 Apr; 18(4):360-4. PubMed ID: 9537419
[TBL] [Abstract][Full Text] [Related]
12. A silencer element in the retinoblastoma tumor-suppressor gene.
Ohtani-Fujita N; Fujita T; Takahashi R; Robbins PD; Dryja TP; Sakai T
Oncogene; 1994 Jun; 9(6):1703-11. PubMed ID: 8183566
[TBL] [Abstract][Full Text] [Related]
13. Unbiased analysis of RB-mediated transcriptional repression identifies novel targets and distinctions from E2F action.
Markey MP; Angus SP; Strobeck MW; Williams SL; Gunawardena RW; Aronow BJ; Knudsen ES
Cancer Res; 2002 Nov; 62(22):6587-97. PubMed ID: 12438254
[TBL] [Abstract][Full Text] [Related]
14. Regulation of RB transcription in vivo by RB family members.
Burkhart DL; Ngai LK; Roake CM; Viatour P; Thangavel C; Ho VM; Knudsen ES; Sage J
Mol Cell Biol; 2010 Apr; 30(7):1729-45. PubMed ID: 20100864
[TBL] [Abstract][Full Text] [Related]
15. Neural precursor cells differentiating in the absence of Rb exhibit delayed terminal mitosis and deregulated E2F 1 and 3 activity.
Callaghan DA; Dong L; Callaghan SM; Hou YX; Dagnino L; Slack RS
Dev Biol; 1999 Mar; 207(2):257-70. PubMed ID: 10068462
[TBL] [Abstract][Full Text] [Related]
16. Loss of the retinoblastoma tumor suppressor: differential action on transcriptional programs related to cell cycle control and immune function.
Markey MP; Bergseid J; Bosco EE; Stengel K; Xu H; Mayhew CN; Schwemberger SJ; Braden WA; Jiang Y; Babcock GF; Jegga AG; Aronow BJ; Reed MF; Wang JY; Knudsen ES
Oncogene; 2007 Sep; 26(43):6307-18. PubMed ID: 17452985
[TBL] [Abstract][Full Text] [Related]
17. E2F-HDAC complexes negatively regulate the tumor suppressor gene ARHI in breast cancer.
Lu Z; Luo RZ; Peng H; Huang M; Nishmoto A; Hunt KK; Helin K; Liao WS; Yu Y
Oncogene; 2006 Jan; 25(2):230-9. PubMed ID: 16158053
[TBL] [Abstract][Full Text] [Related]
18. LXCXE-independent chromatin remodeling by Rb/E2f mediates neuronal quiescence.
Andrusiak MG; Vandenbosch R; Dick FA; Park DS; Slack RS
Cell Cycle; 2013 May; 12(9):1416-23. PubMed ID: 23574720
[TBL] [Abstract][Full Text] [Related]
19. E2F1 mediates ectopic proliferation and stage-specific p53-dependent apoptosis but not aberrant differentiation in the ocular lens of Rb deficient fetuses.
Liu Y; Zacksenhaus E
Oncogene; 2000 Dec; 19(52):6065-73. PubMed ID: 11146559
[TBL] [Abstract][Full Text] [Related]
20. Cooperation of E2F-p130 and Sp1-pRb complexes in repression of the Chinese hamster dhfr gene.
Chang YC; Illenye S; Heintz NH
Mol Cell Biol; 2001 Feb; 21(4):1121-31. PubMed ID: 11158299
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
